Patent · US Active

Methods of identifying and treating glioblastoma

US9587239B2 · kind B2 · utility

0Cited by
3References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 23, 2015
Grant dateMar 7, 2017
Priority date
Expiry dateFeb 23, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/158
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention encompasses methods and kits used in the detection of invasive glioblastoma based upon the expression of NHERF-1. The methods and kits also allow prediction of disease outcome as well as therapeutic outcome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.